ENDRA Life Sciences Inc (OQ:NDRA)

Business Focus: Biotechnology & Medical Research

INK Ultra Money Free

Latest 10 SEC filings (by transaction date) for NDRA within the last 6 months [?]
Amended Filing      Footnote and/or Remark
As of 11:59pm ET May 25th, 2020
Filing
Date
Transaction
Date
Insider Name Ownership
Type
Securities Nature of transaction Volume or Value Price
May 22/20 May 21/20 Basenese Lou Direct Ownership Common Stock P - Open market or private purchase 10,000 $0.710
Apr 15/20 Apr 15/20 Basenese Lou Direct Ownership Common Stock Form 3 : Initial Statement of Beneficial Ownership of Securities    
Apr 15/20 Apr 9/20 Basenese Lou Direct Ownership Stock Option (right to buy) A - Grant, award or other under Rule 16b-3(d) 50,000  
Apr 15/20 Apr 9/20 Basenese Lou Direct Ownership Common Stock A - Grant, award or other under Rule 16b-3(d) 41,587  
Apr 13/20 Apr 9/20 Gambhir Sanjiv Sam Direct Ownership Common Stock A - Grant, award or other under Rule 16b-3(d) 42,857  
Apr 13/20 Apr 9/20 Tokman Alexander Y Direct Ownership Common Stock A - Grant, award or other under Rule 16b-3(d) 42,857  
Apr 13/20 Apr 9/20 Harsh Michael Direct Ownership Common Stock A - Grant, award or other under Rule 16b-3(d) 42,857  
Apr 13/20 Apr 9/20 Digiandomenico Anthony Direct Ownership Common Stock A - Grant, award or other under Rule 16b-3(d) 42,857  
Apr 13/20 Apr 9/20 Maloberti Renaud Bertrand Direct Ownership Common Stock A - Grant, award or other under Rule 16b-3(d) 86,580  
Apr 13/20 Apr 9/20 Wells David R. Direct Ownership Common Stock A - Grant, award or other under Rule 16b-3(d) 79,653  
Sign up or login above to see all SEC filings within the past 6 months.
Latest 10 SEC filings (by filing date) for NDRA within the last 6 months [?]
Amended Filing      Footnote and/or Remark
As of 11:59pm ET May 25th, 2020
Filing
Date
Transaction
Date
Insider Name Ownership
Type
Securities Nature of transaction Volume or Value Price
May 22/20 May 21/20 Basenese Lou Direct Ownership Common Stock P - Open market or private purchase 10,000 $0.710
Apr 15/20 Apr 9/20 Basenese Lou Direct Ownership Stock Option (right to buy) A - Grant, award or other under Rule 16b-3(d) 50,000  
Apr 15/20 Apr 9/20 Basenese Lou Direct Ownership Common Stock A - Grant, award or other under Rule 16b-3(d) 41,587  
Apr 15/20 Apr 15/20 Basenese Lou Direct Ownership Common Stock Form 3 : Initial Statement of Beneficial Ownership of Securities    
Apr 13/20 Apr 9/20 Gambhir Sanjiv Sam Direct Ownership Common Stock A - Grant, award or other under Rule 16b-3(d) 42,857  
Apr 13/20 Apr 9/20 Tokman Alexander Y Direct Ownership Common Stock A - Grant, award or other under Rule 16b-3(d) 42,857  
Apr 13/20 Apr 9/20 Harsh Michael Direct Ownership Common Stock A - Grant, award or other under Rule 16b-3(d) 42,857  
Apr 13/20 Apr 9/20 Digiandomenico Anthony Direct Ownership Common Stock A - Grant, award or other under Rule 16b-3(d) 42,857  
Apr 13/20 Apr 9/20 Maloberti Renaud Bertrand Direct Ownership Common Stock A - Grant, award or other under Rule 16b-3(d) 86,580  
Apr 13/20 Apr 9/20 Wells David R. Direct Ownership Common Stock A - Grant, award or other under Rule 16b-3(d) 79,653  
Sign up or login above to see all SEC filings within the past 6 months.
Sign up or login above to see the past 6 months of filings sorted by insider. .
Get holdings trends & enhanced insider charts in PDF now

Twitter

Search (past week) for $NDRA

Competitors

Competitors with Recent Insider Filings
Iqvia Holdings (N:IQV)
Seattle Genetics (OQ:SGEN)
Alnylam Pharmaceuticals (OQ:ALNY)